Optina Diagnostic

Optina has developed specialized hardware and proprietary A.I. software that enables a simple eye-scan to detect key biomarkers of cognitive diseases, first focused on Alzheimer’s disease. With pilots underway, their technology slashes pharma trial recruitment costs, dramatically improves patient diagnostics, catching

Optina Diagnostic is a business in biotechnology, medical device based in Montral, Quebec, CA, founded in 2011.

Profile

Optina has developed specialized hardware and proprietary A.I. software that enables a simple eye-scan to detect key biomarkers of cognitive diseases, first focused on Alzheimer’s disease. With pilots underway, their technology slashes pharma trial recruitment costs, dramatically improves patient diagnostics, catching cognitive decline much sooner for better management of cognitively-impaired populations.

Within the biotechnology, medical device space, the company focuses on its core offering rather than a broad product line.

Montral, Quebec, CA is where the company is located.

It is recorded at the Series_A stage.

Its team size is recorded as c_00011_00050 employees.

Total disclosed funding stands at about $25.2M.

Website: optinadx.com